The purpose of this study is to compare the effects of the research medicine, solrikitug, with a placebo to find out which is better for treating eosinophilic esophagitis (EoE) in adult patients. The purpose is to see if the research medicine helps improve EoE symptoms: dysphagia (difficulty swallowing), tissue inflammation, clinical symptoms and quality of life.
At each visit, you will meet with a member of the study team to monitor your health, collect blood, and complete questionnaires. There are two study-Endoscopies (where a camera looks inside your throat for any problems). During the study treatment, you will come into the clinic for study medicine administration every 4 weeks.
Information provided upon request, 2 study-paid endoscopies (where a camera looks inside your throat for any problems)
Clinical and Translational Research Center (CTRC)
Burnett-Womack Building (UNC-Chapel Hill)
160 Dental Cir, Chapel Hill, NC 27514, USA
Evan Dellon
Medicine-Gastroenterology
Clinical or Medical
Interventional
Allergy
Chronic Conditions
Stomach, Digestion and Gut Health
Rare Diseases
Women's Health
Men's Health
24-1306
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
